Phase 4RecruitingINTERVENTIONAL
Liraglutide Treatment in Obese Infertile PCOS Women
ClinicalTrials.gov · NCT06742710 · Registry updated: 2025-05-29
- Condition / research focus
- PCOS; Obesity; Infertility
- Sponsor
- Peking University Third Hospital
- Countries with listed sites
- China
- Registry dates and results
- Start: 2025-05-22. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Liraglutide and metformin (drug)
- Metformin (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Peking University Third Hospital
Beijing, Beijing Municipality, China
Site recruitment: Recruiting - Beijing Obstetrics and Gynecology Hospital
Beijing, China
Site recruitment: Not yet recruiting - Haidian District Maternal and Child Health Care Hospital
Beijing, China
Site recruitment: Not yet recruiting